Christian J. Krautkramer
The drug Neurontin is used as an example of why it is permissible for physicians to engage in off-label prescribing, but off-label marketing by pharmaceutical companies is prohibited by the FDA.
Virtual Mentor. 2006; 8(6):397-402. doi:
10.1001/virtualmentor.2006.8.6.hlaw1-0606.